دانلود کتاب Evidence-Based Hematology

This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients. The book is split into two sections: the first examines the methodology underlying evidence based practice, and the second concentrates on the clinical practice of hematology, providing current “best evidence” to guide practice in a series of well-defined clinical situations. This clinical reference is an invaluable source of evidence-based information distilled into guidance for clinical practice which will be welcomed by practitioners, trainees and associated health professionals.Content: Chapter 1 Rating the Quality of Evidence and Making Recommendations: A Guide to the Spectrum of Clinical Research (pages 1–9): Holger J. Schunemann, Martin Stanulla, Jan L. Brozek and Gordon G. GuyattChapter 2 An Overview of Systematic Reviews (pages 10–14): Martin Prins, Arina ten Cate?Hoek and Pieter LeffersChapter 3 Interpreting Results in Clinical Research: Overview of Measures of Effect, Measures of Precision, and Measures of Diagnostic Accuracy for Clinicians and Researchers (pages 15–22): Marcello Di Nisio, Harry R. Buller and Patrick M. M. BossuytChapter 4 Finding the Evidence in Hematology (pages 23–31): K. Ann McKibbon, Cynthia J. Walker?Dilks and R. Brian HaynesChapter 5 Applying EBM in Clinical Practice (pages 32–36): Alessandro Squizzato, Walter Ageno and Davide ImbertiChapter 6 Using Evidence to Guide the Diagnosis of Disease (pages 37–45): Lucas M. Bachmann and Holger J. SchunemannChapter 7 Diagnosis of Deep Vein Thrombosis (pages 47–55): Lori?Ann LinkinsChapter 8 The Diagnosis of Acute Pulmonary Embolism (pages 56–64): Victor F. TapsonChapter 9 Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism (pages 65–72): Sam SchulmanChapter 10 Long?Term Anticoagulation in Venous Thromboembolism (pages 73–87): Clive KearonChapter 11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism (pages 88–98): Simon J. McRae and John W. EikelboomChapter 12 Inferior Vena Cava Interruption (pages 99–109): Michael B. Streiff and Christine L. HannChapter 13 Management of Venous Thromboembolism in Pregnancy (pages 110–119): Wee?Shian ChanChapter 14 Pediatric Thrombosis (pages 120–123): Anthony K. C. Chan and Paul MonagleChapter 15 Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Surgery (pages 124–130): James D. Douketis and Scott KaatzChapter 16 Evidence?Based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura (pages 131–137): Brian Boulmay and Craig S. KitchensChapter 17 Diagnosis and Management of Disseminated Intravascular Coagulation (pages 138–144): Julia A. M. AndersonChapter 18 Diagnosis and Management of Hereditary Bleeding Disorders: Including Congenital/Acquired Platelet Function Disorders (pages 145–151): Nigel S. Key and Alice D. MaChapter 19 Diagnosis and Management of Acquired Bleeding Disorders: Vitamin K Antagonists (pages 152–157): Miguel A. EscobarChapter 20 Diagnosis and Management of Heparin?Induced Thrombocytopenia (pages 158–167): Theodore E. Warkentin and Andreas GreinacherChapter 21 Management of Antiphospholipid Antibody Syndrome (pages 168–175): Wendy Lim and Mark A. CrowtherChapter 22 Clinical Questions in Iron Overload (pages 177–188): Antonello Pietrangelo and Nicola MagriniChapter 23 Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia (pages 189–196): Shivani Srivastava and Richard W. ChildsChapter 24 Acquired Anemias: Iron Deficiency, Cobalamin Deficiency, and Autoimmune Hemolytic Anemia (pages 197–205): Marc S. Zumberg and Marc J. KahnChapter 25 Immune Thrombocytopenic Purpura (pages 206–214): James N. George, Sara K. Vesely and George R. BuchananChapter 26 Neutropenia (pages 215–220): David C. DaleChapter 27 Hypereosinophilia: Primary and Secondary (pages 221–228): Florence Roufosse, Michel Goldman and Elie CoganChapter 28 Porphyrias (pages 229–237): Gagan Sood and Karl E. AndersonChapter 29 Membrane and Enzyme Abnormalities of the Erythrocyte (pages 238–243): Patrick G. Gallagher and Ernest BeutlerChapter 30 Sickle Cell Disease (pages 244–250): Richard Lottenberg and Sally C. DaviesChapter 31 Evidence?Based Treatment of Thalassemia Major (pages 251–259): Issac Odame and Deborah RundChapter 32 Acute Lymphoblastic Leukemia in Adults (pages 261–267): Stephen Couban and Andrea KewChapter 33 Acute Myeloid Leukemia in Adults: Remission Induction Therapy (pages 268–277): Cara A. Rosenbaum and Richard A. LarsonChapter 34 Acute Myeloid Leukemia in Adults: Postremission Therapy (pages 278–286): Cara A. Rosenbaum and Richard A. LarsonChapter 35 Current Areas of Controversy in the Treatment of Patients with Newly Diagnosed Acute Promyelocytic Leukemia (pages 287–293): Martin S. Tallman and Syed A. AbutalibChapter 36 Chronic Lymphocytic Leukemia (pages 294–299): Bruce D. ChesonChapter 37 Chronic Myeloid Leukemia (pages 300–304): Irwin WalkerChapter 38 Selected Management of Patients with Myelodysplastic Syndromes (pages 305–310): John M. Storring and Karen W. L. YeeChapter 39 Evidence?Based Treatment of Burkitt Lymphoma in Adults (pages 311–316): John Gerecitano and David J. StrausChapter 40 Primary Central Nervous System Lymphoma (pages 317–326): Tamara ShenkierChapter 41 Diffuse Large B?Cell Lymphoma (pages 327–333): Michael CrumpChapter 42 Follicular Lymphoma (pages 334–341): Kevin Imrie and Matthew CheungChapter 43 Lymphoblastic Lymphoma (pages 342–346): Tyler Y. Kang and John W. SweetenhamChapter 44 Mantle Cell Lymphoma (pages 347–351): C. Tom KouroukisChapter 45 Management of Patients with Peripheral T?Cell Lymphoma (pages 352–364): Kerry J. SavageChapter 46 Selected Management Issues of Patients with Hodgkin Lymphoma (pages 365–371): Ralph M. MeyerChapter 47 Lymphocyte Predominant Hodgkin Lymphoma (pages 372–377): Brandon McMahon and Jonathan W. FriedbergChapter 48 Management of Patients with Essential Thrombocythemia (pages 378–384): Guido Finazzi, Giovanni Barosi and Tiziano BarbuiChapter 49 Management of Patients with Polycythemia Vera (pages 385–389): Guido Finazzi, Roberto Marchioli and Tiziano BarbuiChapter 50 Evidence?Based Review of Therapies in Multiple Myeloma (pages 390–395): Michael Sebag and A. Keith StewartChapter 51 Management of Waldenstrom's Macroglobulinemia (pages 396–401): Christine I. ChenChapter 52 The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies (pages 402–411): Heloisa P. Soares, Ambuj Kumar, Charles Bennett and Benjamin Djulbegovic